Theriva Biologics, Inc. (TOVX) Tops Q3 EPS by 23c

Theriva Biologics, Inc. (NYSE: TOVX) reported Q3 EPS of ($0.19), $0.23 better than the analyst estimate of ($0.42).

For earnings history and earnings-related data on Theriva Biologics, Inc. (TOVX) click here.

You May Also Be Interested In

• Sprinklr (CXM) Tops Q2 EPS by 1c, Offers Guidance
• DA Davidson Reiterates Buy Rating on CrowdStrike (CRWD) Ahead of User Conference
• Rex American Resources Corp. (REX) Tops Q2 EPS by 64c